Taro Pharmaceutical Industries Other Current Liabilities

Taro Pharmaceutical Industries (TARO) currently reports a other current liabilities of $320M as of March 2024. That compares with $310M in the prior-year period — up 0.7% year over year. Use the charts on this page to explore Taro Pharmaceutical Industries's other current liabilities history and peer comparisons.

Taro Pharmaceutical Industries's other current liabilities increased from $310M to $320M — a 0.7% year-over-year increase (period ending March 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Taro Pharmaceutical Industries reported $320M in other current liabilities as of March 2024. That compares with $310M in the prior-year period — up 0.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other current liabilities of $320M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Taro Pharmaceutical Industries, and consider following TARO for alerts when major investors trade the stock.

Taro Pharmaceutical Industries is classified in the Healthcare sector. On other current liabilities, it currently shows $320M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing TARO with unrelated industries.